Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Alf Bernhardt is listed as Global Medical Affairs @Early Development | CellTherapy | Pharmadevelopment | Global and Regional Leadership | Hematologist, Oncologist, MD at ViferaXS, based in Muttenz, Basel-Country, Switzerland. AeroLeads shows a matched LinkedIn profile for Alf Bernhardt.
Alf Bernhardt previously worked as Consulting CMO to ViferaXS at Viferaxs and Head of Pipeline and Cell Therapy Global Medical Affairs Takeda Oncology at Takeda Oncology. Alf Bernhardt holds Staatsexamen, Humanmedizin from Heinrich-Heine-Universität Düsseldorf.
This section adds company-level context without repeating Alf Bernhardt's masked contact details.
Review company-level records connected to Alf Bernhardt before choosing the right outreach path.
With over 18 years of experience in oncology and hematology, I have a strong background in clinical research, medical affairs, and product launch in global and regional markets. My mission is to advance the science and practice of IO treatments annd CellTherapies to ensure the best outcomes for patients. I have lead and supported the development and launch of several novel therapeutics and biomarkers for lymphoma, breast cancer, and other oncology indications. I have also contributed to multiple publications, patents, and certifications in the field of oncology and hematology. I am passionate about improving patients' lives and delivering excellence in medical affairs and translational science.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Basel-Country, Switzerland
In my role as Consulting CMO to ViferaXS, I spearheaded the development of a groundbreaking T-cell activating anti-cancer vaccination based on innovative protein profiles. Working closely with Prof. Dr. Juliane Walz and her team at University Tübingen, Germany, we successfully translated academic research into a viable treatment option for patients, contributing to the advancement of cancer care.
Cambridge, Massachusetts, Vereinigte Staaten Von Amerika
Head of the Global Medical Oncology Affairs Pipeline and Cell Therapies Teams
Zurich, Switzerland
Head of Cell Therapy building a global medical affairs team to bring innovative Cell Therapies to patients
Zug, Switzerland
Department Head, building the Medical Affairs regional organization including hiring CMDs and prepare the launch of Tucatinib in Europe
Basel
Global Medical Team lead covering Herceptin, Kadcyla, Perjeta and HER2+ CIT
Grenzach-Wyhlen
Managing and recruiting up to 8 MSLs in the hematology franchise responsible for line management and medical/scientific leadership
Germany
Responsible for medical strategy of the heme franchise Germany including late stage portfolio and scientific advisor for early and later development trials on regional basis
Düsseldorf Und Umgebung, Deutschland
Activities and Societies: DFA/DAAD: Local Exchange Officer at the HHU and NOA (National Officer on AIDS and STD) until 1999
Quick answers generated from the profile data available on this page.
Alf Bernhardt works for ViferaXS.
Alf Bernhardt is listed as Global Medical Affairs @Early Development | CellTherapy | Pharmadevelopment | Global and Regional Leadership | Hematologist, Oncologist, MD at ViferaXS.
Alf Bernhardt is based in Muttenz, Basel-Country, Switzerland while working with ViferaXS.
Alf Bernhardt has worked for Viferaxs, Takeda Oncology, Seattle Genetics, Roche, and Onkologische Fachklinik Öschelbronn.
You can use AeroLeads to view verified contact signals for Alf Bernhardt at ViferaXS, including work email, phone, and LinkedIn data when available.
Alf Bernhardt holds Staatsexamen, Humanmedizin from Heinrich-Heine-Universität Düsseldorf.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts